SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas

Overview of attention for article published in Frontiers in oncology, October 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 7,408 followers.

SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1... https://t.co/n2TALggpog

25 Oct 2021

Reply Repost Favourite

RT @FrontOncology: New research: SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas…

06 Oct 2021

Reply Repost Favourite

New research: SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas: Patients with germline neurofibromatosis type 1 (NF1) microdeletions frequently exhibit hereditary syndromes such as… https://t.co/mN8

06 Oct 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.